T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 12 clinical trials
featured
A Prospective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated With Valchlor®

A Prospective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma and

  • 538 views
  • 23 Nov, 2020
  • 1 location
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

This is an open label, multi-cohort, and multi-center phase II study, which evaluates the clinical activity and safety of IPH4102 in Sezary Syndrome and Mycosis fungoides as single agent.

beta-hcg
mycosis
peripheral t-cell lymphoma
fungal infection
t-cell lymphoma
  • 26 views
  • 21 Nov, 2020
  • 36 locations
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides

This is a phase II study to evaluate the antitumor activity and safety of AFM13 given as monotherapy in patients with CD30-positive T-cell lymphoma. The investigational medicinal product AFM13

cancer
systemic therapy
brentuximab vedotin
peripheral t-cell lymphoma
mycosis fungoides
  • 32 views
  • 29 Nov, 2020
  • 69 locations
Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or S zary Syndrome (SS)

The purpose of this study is to determine whether resminostat will be able to delay or prevent worsening of disease in patients with advanced stage mycosis fungoides or Szary Syndrome that have recently achieved disease control with previous systemic therapy.

systemic therapy
chemotherapy regimen
mycosis
bexarotene
sezary syndrome
  • 898 views
  • 28 Nov, 2020
  • 92 locations
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

This phase I trial studies the side effects and best dose of anti-inducible T-cell co-stimulator (ICOS) monoclonal antibody MEDI-570 in treating patients with peripheral T-cell lymphoma

cancer
large cell lymphoma
cell transplantation
neutrophil count
monoclonal antibodies
  • 1105 views
  • 29 Nov, 2020
  • 17 locations
Assessing An Oral Janus Kinase Inhibitor AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)

peripheral T cell lymphoma, who have progressed on or are refractory/intolerable to standard systemic treatment. Phase 1 part: Around 20~40 patients will be subsequently enrolled into 2

systemic therapy
measurable disease
t-cell lymphoma
  • 0 views
  • 02 Dec, 2020
  • 1 location
A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

This trial will study brentuximab vedotin to find out whether it is an effective treatment for Hodgkin lymphoma (HL) and peripheral T-cell lymphoma (PTCL). Participants in this study will be

classical hodgkin lymphoma
chemotherapy regimen
brentuximab vedotin
bendamustine
peripheral t-cell lymphoma
  • 220 views
  • 24 Nov, 2020
  • 53 locations
A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies

This is a single-arm, open-label, multicenter, Phase 1 study evaluating the safety and efficacy of CTX130 in subjects with relapsed or refractory T or B cell malignancies.

cancer
b-cell lymphoma
diffuse large b-cell lymphoma
large b-cell lymphoma
  • 0 views
  • 21 Nov, 2020
  • 3 locations
Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies

Background Some T-cell lymphomas and leukemias do not respond to standard treatment. Researchers hope to develop a treatment that works better than current treatments. Objective To test if interleukin (IL-5) combined with avelumab is safe and effective for treating certain cancers. Eligibility People ages 18 and older with relapsed T-cell …

cancer
mycosis
avelumab
pet scans
brentuximab vedotin
  • 18 views
  • 02 Dec, 2020
  • 1 location
Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome

Background Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Sezary syndrome (MF/SS) are cancers that form in the T cells, a type of white blood cell that helps with the body s immune response. A combination of drugs might be able to better treat these cancers than existing therapies. Objective To test …

cancer
MRI Scan
mycosis fungoides and sezary syndrome
mycosis
sezary syndrome
  • 6 views
  • 02 Dec, 2020
  • 1 location